Mescocanal Shunt Plus Pericardial Devascularization in the Treatment of Portal Hypertension Bleeding

Objective To prevent postoperative recurrent bleeding and hepatic encephalopathy due to portal hypertension. Methods Twenty-eight patients with portal hypertension bleeding received side-side or bridge mesocaval shunt in combination with pericardial devascularization and splenectomy. HZ]Results Liver function damage was not aggravated in 23 cases after the operation,all cases got short-term hemostasis,and in the operation there was no death.Follow-up was carried out at 1,3,5 and 10 years and the recurrent rates bleeding were 4.0%(1/25),4.2%(1/24),9.5%(2/21),14.3%(2/14),respectively.The survival rates at 1,3,5,and 10 years were 96.0%(24/28),91.6%(22/24),80.9%(17/21),64.2%(9/14),respectively. Conclusion[WT5”BZ] The operation is effective for controlling portal hypertension without serious damage on liver function.The effect of long-and short-term hemostasis is good.The incidence rate of recurrent bleeding and hepatic encephalopathy is low.